MDi today announced the grant of two further European patents, EP 1 723 921 and EP 1 726 268. These patents form a key part of the intellectual property portfolio underpinning the MicroBlate® tissue ablation technology.

Current innovations
An image of two surgeons

MDi's latest innovations...
Case Studies and details on MDi's latest projects.

Our commitment
An image of an experiment

MDi: our commitment to you...
MDi is the first medical device development and IP management company to be established in Europe.